---
title: USJCMSP 2024 EID
---

- [Grants & Procurement](https://www.crdfglobal.org/grants-procurement/)
- [Contact Us](https://www.crdfglobal.org/contact-us/)

[Facebook](https://www.facebook.com/CRDFGlobal) <https://twitter.com/CRDFGlobal> [Instagram](https://www.instagram.com/crdfglobal/)[Linkedin](https://www.linkedin.com/company/crdf-global)

[![](https://insights.crdfglobal.org/hubfs/crdf-logo.svg)](https://crdfglobal.org/)

- WHO WE ARE
  
  #### [Our Story](https://crdfglobal.org/our-story/)
  
  #### [Mission, Vision & Values](https://crdfglobal.org/mission-vision-values/)
  
  #### [Leadership](https://crdfglobal.org/leadership)
  
  #### [Our Experts](https://crdfglobal.org/experts)
  
  #### [Clients & Partners](https://crdfglobal.org/partners)

  ![Who we are mega menu](https://www.crdfglobal.org/wp-content/uploads/2022/06/who-we-are-menu.jpg)
  
  More than 30 years advancing international security, technology, and economic progress in over 120 countries.
- WHAT WE DO
  
  #### [Chemical, Biological & Nuclear Security](https://www.crdfglobal.org/what-we-do/cbrne-security-counterproliferation/)
  
  #### [Cybersecurity & Digital Resilience](https://www.crdfglobal.org/what-we-do/cybersecurity/)
  
  #### [Research, Data & Emerging Technology Security](https://www.crdfglobal.org/what-we-do/research-data-and-technology-security/)

  #### [Security Cooperation & Exchanges](https://www.crdfglobal.org/what-we-do/international-exchanges/)
  
  #### [Border Security & Strategic Trade Controls](https://www.crdfglobal.org/what-we-do/strategic-trade-border-security/)
  
  #### [Health Security and Research](https://www.crdfglobal.org/what-we-do/global-health/)

  ![What we do mega menu](https://www.crdfglobal.org/wp-content/uploads/2022/07/MegaMenu_Website_Images_Ratios_SizesWhat-We-Do-Mega-Menu.png)
  
  Addressing evolving security and prosperity challenges through strategically tailored solutions.
- HOW WE DELIVER
  
  ### CORE CAPABILITIES
  
  #### [Travel & Logistics](https://crdfglobal.org/capabilities/travel-logistics/)
  
  #### [Specialized Equipment Procurement](https://crdfglobal.org/capabilities/specialized-equipment-procurement/)
  
  #### [Technical & Professional Trainings](https://crdfglobal.org/capabilities/technical-and-professional-trainings/)
  
  #### [Fellowships & Exchanges](https://crdfglobal.org/capabilities/fellowships-and-exchanges/)
  
  #### [Grants & Research Competitions](https://crdfglobal.org/capabilities/grants-research-competitions/)
  
  #### [Security Strengthening](https://crdfglobal.org/capabilities/security-strengthening/)

  ### INTEGRATED SOLUTIONS
  
  #### [Program Design and Management](https://crdfglobal.org/integrated-solutions/program-design-and-management/)
  
  #### [Quality Framework](https://crdfglobal.org/integrated-solutions/quality-framework/)
  
  #### [Monitoring, Evaluation and Learning](https://crdfglobal.org/integrated-solutions/monitoring-evaluation-and-learning/)
  
  #### [Remote Training & Learning](https://crdfglobal.org/integrated-solutions/remote-training-and-learning/)

  ![How we deliver mega menu](https://www.crdfglobal.org/wp-content/uploads/2022/01/how-we-deliver-menu-v2.jpg)
  
  Recognized leader in global program delivery, combining technical expertise with flexible, locally driven solutions.
- [WHERE WE WORK](https://crdfglobal.org/where-we-work/)
- [NEWS & INSIGHTS](https://www.crdfglobal.org/news/)
- [CAREERS](https://crdfglobal.org/careers/)

- [\> Home](https://insights.crdfglobal.org/usjcmspeid2024)
- [\> General Registration](https://insights.crdfglobal.org/usjcmspeid2024-1)
- [\> Speaker Registration](https://insights.crdfglobal.org/usjcmspeid2024-1-1)
- [\> Plenary Agenda](https://insights.crdfglobal.org/usjcmspeid2024-agenda)
- [\> Panel Agendas](https://insights.crdfglobal.org/usjcmspeid2024panels)
- [\> Travel Information](https://insights.crdfglobal.org/usjcmspeid2024-travel)
- [\> IDRIC Symposium](https://idric.kr/)
- [\> Abstract eBooks](https://insights.crdfglobal.org/usjcmspeid2024_ebooks)

---

![USJCMSP logo5 title](https://insights.crdfglobal.org/hs-fs/hubfs/USJCMSP%20logo5%20title.jpg?width=300&height=179&name=USJCMSP%20logo5%20title.jpg "USJCMSP logo5 title")

## The Joint 24th International Conference on Emerging Infectious Diseases in the Pacific Rim of the U.S.-Japan Cooperative Medical Sciences Program (USJCMSP) in collaboration with the 2nd International Symposium for Infectious Diseases Research Institutes Cooperation (IDRIC)

![logo1 (003)](https://insights.crdfglobal.org/hs-fs/hubfs/logo1%20(003).png?width=125&height=125&name=logo1%20(003).png "logo1 (003)")

![NIH\_Master\_Logo\_Vertical\_2Color-PNG (002)](https://insights.crdfglobal.org/hs-fs/hubfs/NIH_Master_Logo_Vertical_2Color-PNG%20(002).png?width=125&height=110&name=NIH_Master_Logo_Vertical_2Color-PNG%20(002).png "NIH_Master_Logo_Vertical_2Color-PNG (002)")

![KDCA\_KNIH\_KNIID LOGO change](https://insights.crdfglobal.org/hs-fs/hubfs/KDCA_KNIH_KNIID%20LOGO%20change.jpg?width=350&height=58&name=KDCA_KNIH_KNIID%20LOGO%20change.jpg "KDCA_KNIH_KNIID LOGO change")

![IVI\_logo (002)-1](https://insights.crdfglobal.org/hs-fs/hubfs/IVI_logo%20(002)-1.png?width=250&name=IVI_logo%20(002)-1.png "IVI_logo (002)-1")

Disclaimer: The views expressed in written conference materials or publications and by speakers and moderators at HHS-sponsored conferences do not necessarily reflect the official policies of the Department of Health and Human Services (HHS), nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

---

### Acute Respiratory Infections Panel Agenda

###### Thursday| 7 March 2024 | DAY THREE

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

8:20-8:30 | Opening Remarks & Introduction - ARI Panel Chairs

- Dr. Yohei Doi | University pf Pittsburgh & Fujita Health University
- Dr. Jorge Vidal | University of Mississippi Medical Center

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

SESSION ONE: SARS-CoV 2: Current Advances and Tracking Viral Evolution

8:30-9:00 | The infectivity of SARS-CoV-2 in immunocompromised patients and their de-isolation | **Masahiro Ishikane,** National Center for Global Health and Medicine, Tokyo, Japan

9:00-9:30 | Epstein-Barr Virus Disrupts Sphingolipid Metabolism to Maintain Viral Latency in Gastric Carcinoma | **Suk Kyeong Lee,** The Catholic University of Korea

9:30-10:00 | Pathological Analysis of COVID-19 Cases and Animal Model Development | **Tadaki Suzuki,** National Institute of Infectious Diseases, Tokyo, Japan

10:00-10:30 | The impact of COVID-19 on community and household cohorts in New Zealand | **Sue Huang, Ph.D,** Institute for Environmental and Science Research, New Zealand

10:30-11:00 | Induction of mucosal antibody responses by SARS-CoV-2 mRNA vaccination in previously infected individuals | **Kaori Sano,** National Institute of Infectious Diseases, Tokyo, Japan

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

11:00-11:10 | Coffee Break

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

SESSION TWO: RSV and Other Viral Respiratory Infections

11:10-11:40 | Evaluation of Virus Detection using Quantitative Multiplex PCR in Pediatric Patients Hospitalized with Respiratory Tract Infections | **Yuto Yasui,** Kawasaki Medical University, Kurashiki, Japan

11:40-12:10 | The impact of influenza A H3N2 evolution from 1968 to 2023 on polymerase activity |  
**Tohru Sakamoto,** Kurume University, Kurume, Japan

12:10-12:40 | **Disease burden of respiratory syncytial virus (RSV) infection in the pediatric population in Japan | Koo Nagasawa,** Chiba University, Chiba, Japan

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

12:40-13:30 | Lunch Break

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

SESSION THREE: Influenza: an Emerging and Re-Emerging Pathogen 

13:30-14:00 | Detection of A(H3N2) influenza viruses with PA/I38T drug resistance substitution after and prior to baloxavir marboxil treatment during the 2022-2023 influenza season in Japan | **Irina Chon,** Niigata University, Niigata, Japan

14:00-14:30 | Does the evolution of human influenza viruses predict influenza epidemics? | **Manon Ragonnet-Cronin, Ph.D.,** University of Chicago, Chicago, IL

14:30-15:00 | CD8+ T cell immunity directed at Influenza A and Influenza B viruses in First Nations peoples | **Louise Rowntree, Ph.D.,** Peter Doherty Institute, Melbourne, Australia

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

15:00-15:15 | Break 

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

SESSION FOUR: Other Acute Respiratory Infections

15:15-15:45 | Recent trend of respiratory infections in Korea | **Hyukmin Lee, MD, PhD,** Yonsei University, Seoul, Korea

15:45-16:15 | Pathogens Sticking Together: New Synergies Operative in Polymicrobial Infections |  
**Jason Rosch**, **Ph.D.,** St Jude Children’s Research Hospital, Memphis, USA

16:15-17:15 | Closing Remarks - ARI Panel Chairs

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

 

---

## If you have any questions or technical issues please contact Annie King, [aking@crdfglobal.org](mailto:aking@crdfglobal.org)

![](https://www.crdfglobal.org/wp-content/uploads/2021/12/crdf-logo-white.svg)

#### Advancing U.S. national security by mitigating threats and enhancing opportunities through technology, innovation, and collaboration.

### Let us know how we can help you reach your goals

[Facebook Facebook](https://www.facebook.com/CRDFGlobal) [Twitter](https://twitter.com/CRDFGlobal) [Instagram Instagram](https://www.instagram.com/crdfglobal/) [Linkedin Linkedin](https://www.linkedin.com/company/crdf-global)[Contact Us](https://insights.crdfglobal.org/contact-us?hsLang=en)

- WHO WE ARE 
    - [Our Story](https://crdfglobal.org/our-story/)
    - [Mission, Vision & Values](https://crdfglobal.org/mission-vision-values/)
    - [Leadership](https://insights.crdfglobal.org/leadership?hsLang=en)
    - [Our Experts](https://insights.crdfglobal.org/experts?hsLang=en)
    - [Partners](https://insights.crdfglobal.org/partners?hsLang=en)
- WHAT WE DO 
    - [Chemical, Biological & Nuclear Security](https://www.crdfglobal.org/what-we-do/cbrne-security-counterproliferation/)
    - [Cybersecurity & Digital Resilience](https://www.crdfglobal.org/what-we-do/cybersecurity/)
    - [Research, Data & Emerging Technology Security](https://www.crdfglobal.org/what-we-do/research-data-and-technology-security/)
    - [Security Cooperation & Exchanges](https://www.crdfglobal.org/what-we-do/international-exchanges/)
    - [Border Security & Strategic Trade Controls](https://www.crdfglobal.org/what-we-do/strategic-trade-border-security/)
    - [Health Security & Research](https://www.crdfglobal.org/what-we-do/global-health/)
- HOW WE DELIVER 
    - [Travel & Logistics](https://www.crdfglobal.org/capabilities/travel-logistics/)
    - [Security Strengthening](https://www.crdfglobal.org/capabilities/security-strengthening/)
    - [Fellowships & Exchanges](https://www.crdfglobal.org/capabilities/fellowships-and-exchanges/)
    - [Grants & Research Competitions](https://www.crdfglobal.org/capabilities/grants-research-competitions/)
    - [Technical & Professional Training](https://www.crdfglobal.org/capabilities/technical-and-professional-trainings/)
    - [Specialized Equipment Procurement](https://www.crdfglobal.org/capabilities/specialized-equipment-procurement/)
    - [Program Design and Management](https://www.crdfglobal.org/integrated-solutions/program-design-and-management/)
    - [Monitoring, Evaluation and Learning](https://www.crdfglobal.org/integrated-solutions/monitoring-evaluation-and-learning/)
    - [Remote Training & Learning](https://www.crdfglobal.org/integrated-solutions/remote-training-and-learning/)
    - [Quality Framework](https://www.crdfglobal.org/integrated-solutions/quality-framework/)
- COLLABORATE 
    - [Become a Partner](https://www.crdfglobal.org/become-a-partner/)
    - [Grants & Procurement](https://www.crdfglobal.org/grants-procurement/)
    - [Procurement & RFPs](https://insights.crdfglobal.org/rfp?hsLang=en)
    - [Funding & Grants](https://insights.crdfglobal.org/funding-opportunities?hsLang=en)
- [WHERE WE WORK](https://crdfglobal.org/where-we-work/) 
    - [NEWS & INSIGHTS](https://www.crdfglobal.org/news/)
    - [CAREERS](https://www.crdfglobal.org/careers/)

[Privacy Policy](https://www.crdfglobal.org/data-privacy-policy/)    [Code of Conduct](https://www.crdfglobal.org/participant-code-of-conduct/)

© 2026 CRDF Global - All rights reserved